ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$51.10
+0.28%Forward multiples
Based on analyst estimates
- P/E forward
- 31.82x
- P/E 2026E
- 46.27x
- P/E 2027E
- 24.13x
- P/E 2028E
- 16.00x
- P/S forward
- 6.96x
Trailing multiples
Trailing twelve months
- P/E TTM
- 109.88x
- PEG TTM
- 0.44x
- Price / book
- 31.35x
- Price / sales
- 13.83x
- Price / cash flow
- 96.50x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 13.85x
- EV / EBITDA
- 73.31x
- EV / EBIT
- 89.68x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026